The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Radiologic Measurements of Tumor Response to Treatment: Practical Approaches and Limitations
Abstract
Objective response assessment is important to describe the treatment effect of anticancer drugs. Standardization by using a "common language" is also important for comparison of results from different trials. In contrast to clinical results, which can be subjective, diagnostic imaging provides a greater opportunity for objectivity and standardization. It was generally accepted that a decrease in tumor size correlated with treatment effect; as a result, imaging was adopted for lesion measurement in the World Health Organization (WHO) criteria in 1979. However, because of some limitations of the WHO criteria, the Response Evaluation Criteria in Solid Tumors (RECIST) were introduced in 2000. In RECIST, imaging was recognized as indispensable for response evaluation of solid tumors. Nevertheless, the widespread use of multidetector computed tomography and other imaging innovations have made RECIST outdated, with a concomitant need for modifications. Meanwhile, newer anticancer agents with targeted mechanisms of action have demonstrated an inherent limitation and unsuitability of anatomic tumor evaluation that assesses only lesion size. In addition, the effect of these new drugs changes the paradigm according to which tumor response or response rate is measured. Complete and partial responses cannot be the end points in all clinical trials; in some cases, disease control or progression-free survival may be the more relevant end point.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Shepherd, F. A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E. H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., Martins, R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050753 · Cited by 5,419
Thatcher, N., Chang, A., Parikh, P., Rodrigues Pereira, J., Ciuleanu, T., von Pawel, J., Thongprasert, S., Tan, E. H., Pemberton, K., Archer, V., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67625-8 · Cited by 2,079
Cited by
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Sharma, P., Wagner, K., Wolchok, J. D., & Allison, J. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3153 · Cited by 642
HCC and angiogenesis: possible targets and future directions
Zhu, A. X., Duda, D. G., Sahani, D. V., & Jain, R. K. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.30 · Cited by 564
Nishino, M., Jagannathan, J. P., Ramaiya, N. H., & Van den Abbeele, A. D. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.4110 · Cited by 378
Reproducibility and Prognosis of Quantitative Features Extracted from CT Images
Balagurunathan, Y., Gu, Y., Wang, H., Kumar, V., Grove, O., Hawkins, S., Kim, J., Goldgof, D. B., Hall, L. O., Gatenby, R. A., et al. (2014) · Translational Oncology · doi:10.1593/tlo.13844 · Cited by 306
Patterns of Response and Progression to Immunotherapy
Borcoman, E., Nandikolla, A., Long, G., Goel, S., & Le Tourneau, C. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_200643 · Cited by 262
Metadata
- Authors
- Suzuki, C., Jacobsson, H., Hatschek, T., Torkzad, M. R., Bodén, K., Eriksson-Alm, Y., Berg, E., Fujii, H., Kubo, A., & Blomqvist, L.
- Venue
- RadioGraphics
- Published
- 2008-03
- Volume
- 28
- Issue
- 2
- Pages
- 329-344
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W2096340454
- Cited by
- 236
- References
- 3
- FWCI
- 14.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Radiologic Measurements of Tumor Response to Treatment: Practical Approaches and Limitations. https://app.cochat.ai/papers/10.1148/rg.282075068
- The paper
- Suzuki, C., Jacobsson, H., Hatschek, T., Torkzad, M. R., Bodén, K., Eriksson-Alm, Y., Berg, E., Fujii, H., Kubo, A., & Blomqvist, L. (2008). Radiologic Measurements of Tumor Response to Treatment: Practical Approaches and Limitations. RadioGraphics. https://doi.org/10.1148/rg.282075068
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.